Company intelligence / Profile preview

United Health Products

Las Vegas, Nevada, United Statesuhpcorp.com ↗

Ownership: Private
Development stage: NDA

Overview

United Health Products manufactures CelluSTAT™ Absorbable Hemostat, a sterile hemostatic gauze derived from plant cellulose. The product accelerates hemostasis in mild to moderate bleeds and has been submitted for FDA Premarket Approval as of March 2024. Clinical results are not yet public; the product remains unavailable for sale pending regulatory approval.

Therapeutic areas: Hematology
Modalities: Device (Hemostatic gauze)Biologic (derived from natural cellulose)
Industry: Consumable Medical Devices

Drug pipeline

1 asset

CelluSTAT

NDA

Indications: Surgical bleeding control, Dialysis bleeding, Dental bleeding, Emergency medicine bleeding

Partnerships

Manufacturing partnerships with FDA registered partners in the US for sterilization and packaging; specific partner names not disclosed.

Beyond the preview

Go deeper on United Health Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on United Health Products.